miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST

Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors

(2013) Masahiko Kanamori et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Regulation of microRNAs by epigenetics and their interplay involved in cancer

(2013) Xiaolan Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma

(2013) Guangyi Zhao et al.   PLoS One

miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma

(2012) K. B. Jones et al.   CANCER RESEARCH

Circulating microRNAs in cancer: origin, function and application

(2012) Ruimin Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Prognostic value of Twist and E-cadherin in patients with osteosarcoma

(2012) Ke Yin et al.   MEDICAL ONCOLOGY

Phase 1 clinical trials for sarcomas: the cutting edge

(2011) Vivek Subbiah et al.   CURRENT OPINION IN ONCOLOGY

The proto-oncogene Pim-1 is a target of miR-33a

(2011) M Thomas et al.   ONCOGENE

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

(2011) A. Davalos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNAs as therapeutic targets in cancer

(2011) S. Patrick Nana-Sinkam et al.   Translational Research

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

(2010) Bo Song et al.   Molecular Cancer

Twist expression promotes migration and invasion in hepatocellular carcinoma

(2009) Noriyuki Matsuo et al.   BMC CANCER

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

(2009) B Song et al.   ONCOGENE

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols